• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Silver Spike Acquisition Corp II filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    3/13/23 9:30:46 PM ET
    $SPKB
    Blank Checks
    Finance
    Get the next $SPKB alert in real time by email
    false000182643500-000000000018264352023-03-132023-03-130001826435spkb:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member2023-03-132023-03-130001826435spkb:UnitsEachConsistingOfOneClassAOrdinaryShareAndOneFourthOfOneRedeemableWarrantMember2023-03-132023-03-130001826435us-gaap:CommonClassAMember2023-03-132023-03-13

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

    Date of Report (date of earliest event reported): March 13, 2023

    SILVER SPIKE ACQUISITION CORP II
    (Exact name of registrant as specified in its charter)

    Cayman Islands
      001-40182
     
    N/A
    (State or other jurisdiction of incorporation)
     
    (Commission File Number)
     
    (I.R.S. Employer Identification No.)

    600 Madison Avenue, Suite 1800
    New York, New York
     
     
    10022
    (Address of Principal Executive Offices)
     
    (Zip Code)

    Registrant’s telephone number, including area code: +1 212-905-4923

    Not Applicable
    (Former name or former address, if changed since last report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each class
     
    Trading Symbol(s)
     
    Name of each exchange on which
    registered
    Class A ordinary shares, par value $0.0001 per share
     
    SPKB
     
    The NASDAQ Stock Market LLC
    Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
     
    SPKBW
     
    The NASDAQ Stock Market LLC
    Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
     
    SPKBU
     
    The NASDAQ Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☒

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 7.01.
    Regulation FD Disclosure.

    On March 13, 2023, Silver Spike Acquisition Corp II (the “Company”) issued a press release announcing it will redeem all of its outstanding Class A ordinary shares, effective as of March 27, 2023, because the Company will not be able to consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

    The information in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

    Forward-Looking Statements

    This document contains certain “forward-looking statements” within the meaning of the federal securities laws, including with respect to the pursuit by Silver Spike Acquisition Corp II (“Silver Spike II”) of a business combination transaction. These forward-looking statements are generally identified by words such as “anticipate,” “believe,” continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strive,” “would” or the negatives of these words or words of similar meaning. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Such forward-looking statements are based upon the current beliefs and expectations of the management of Silver Spike II and are inherently subject to significant business, economic and competitive risks, uncertainties and contingencies. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Silver Spike, including those set forth in the “Risk Factors” section of Silver Spike II’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Silver Spike’s registration statement, the preliminary prospectus for Silver Spike’s offering and other documents filed by Silver Spike II from time to time with the U.S. Securities and Exchange Commission (the “SEC”). You are cautioned not to place undue reliance on these forward-looking statements as a predictor of future results, performance and/or achievements as projected financial information and other information are based on estimates and assumptions, whether or not identified in this document, that are inherently subject to various significant risks, uncertainties, contingencies and other factors, many of which are difficult to predict and generally beyond the control of the parties involved in the proposed transaction. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Silver Spike II assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Silver Spike II gives no assurance that it will achieve its expectations.


    Item 9.01.
    Financial Statements and Exhibits.

    (d) Exhibits. The following exhibits are filed with this Form 8-K:

    Exhibit No.
     
    Description of Exhibits
         
    99.1
     
    Press Release, dated March 13, 2023
    104
     
    Cover Page Interactive Data File (embedded within the Inline XBRL document)


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Dated: March 13, 2023  
     
    SILVER SPIKE ACQUISITION CORP II
       
     
    By:
    /s/ Scott Gordon
     
    Name:
    Scott Gordon
     
    Title:
    Chief Executive Officer and Chairman
     


    Get the next $SPKB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SPKB

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SPKB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Silver Spike Acquisition Corp II Announces Redemption of Class A Ordinary Shares

    NEW YORK, March 13, 2023 (GLOBE NEWSWIRE) -- Silver Spike Acquisition Corp II (the "Company") today announced that it will redeem all of its outstanding Class A ordinary shares (the "Class A Ordinary Shares"), effective as of March 27, 2023, because the Company will not consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association (the "Articles"). As stated in the Company's Articles, if the Company does not consummate an initial business combination within 24 months of the closing of the Company's initial public offering, or March 15, 2023, the Company will: (i) cease all operations except for the purpose of

    3/13/23 9:23:35 PM ET
    $SPKB
    Blank Checks
    Finance

    Eleusis and Silver Spike Acquisition Corp. II Mutually Agree to Terminate Business Combination Agreement

    Eleusis, a clinical-stage life science company that aims to unlock the therapeutic potential of psychedelics, and Silver Spike Acquisition Corp. II ("Silver Spike II" or "SPKB") (NASDAQ:SPKB), a publicly traded special purpose acquisition company ("SPAC"), today announced that they have mutually agreed to terminate their previously announced agreement and plan of merger (the "Business Combination Agreement"), effective immediately, as a result of current unfavorable market conditions. Silver Spike II intends to continue in its efforts to identify a prospective target business for an initial business combination. Additional information about the termination of the Business Combination Agre

    6/9/22 4:05:00 PM ET
    $SPKB
    Blank Checks
    Finance

    Eleusis Announces Notice of Allowance for US Patent Application with Claims Covering Lead Drug Candidate ELE-Psilo

    Eleusis Holdings Ltd announced today it has received a Notice of Allowance for its proprietary psilocin salt form and accompanying formulations from the US Patent and Trademark Office. This salt form and formulations are being developed as Eleusis' lead drug candidate, ELE-Psilo. ELE-Psilo is an investigational psychedelic drug candidate designed to deliver psilocybin's active moiety, psilocin, by intravenous administration. Psilocybin is a prodrug found naturally in certain species of fungi that is metabolized into its pharmacologically active form, psilocin. Eleusis is developing its proprietary salt form of psilocin to enable practical delivery of psilocin directly, and in the case of E

    3/29/22 8:00:00 AM ET
    $SPKB
    Blank Checks
    Finance

    $SPKB
    SEC Filings

    View All

    SEC Form 15-12G filed by Silver Spike Acquisition Corp II

    15-12G - Silver Spike Acquisition Corp II (0001826435) (Filer)

    4/3/23 5:10:39 PM ET
    $SPKB
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Silver Spike Acquisition Corp II

    25-NSE - Silver Spike Acquisition Corp II (0001826435) (Subject)

    3/24/23 4:10:50 PM ET
    $SPKB
    Blank Checks
    Finance

    Silver Spike Acquisition Corp II filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Silver Spike Acquisition Corp II (0001826435) (Filer)

    3/13/23 9:30:46 PM ET
    $SPKB
    Blank Checks
    Finance

    $SPKB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Silver Spike Acquisition Corp II

    SC 13G - Silver Spike Acquisition Corp II (0001826435) (Subject)

    2/14/23 1:58:15 PM ET
    $SPKB
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Silver Spike Acquisition Corp II (Amendment)

    SC 13G/A - Silver Spike Acquisition Corp II (0001826435) (Subject)

    2/14/23 8:26:46 AM ET
    $SPKB
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Silver Spike Acquisition Corp II (Amendment)

    SC 13G/A - Silver Spike Acquisition Corp II (0001826435) (Subject)

    2/14/23 6:06:05 AM ET
    $SPKB
    Blank Checks
    Finance